Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 1, 1996, Pages 16-20

  Kranzler, Henry R ^a   Escobar, Rodrigo ^a   Lee, Duk Ki ^a   Meza, Eduardo ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Attrition; Pharmacotherapy Trials; Premature Discontinuation; Psychiatric Disorders; Substance Abuse

Indexed keywords

ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; DRUG ABUSE; HUMAN; MEDICAL CARE; MEDICAL RESEARCH; MENTAL DISEASE; PRIORITY JOURNAL; SOCIOPATHY; SUBSTANCE ABUSE;

ALCOHOLISM; COMORBIDITY; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; HUMANS; MENTAL DISORDERS; PATIENT DROPOUTS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 0029866933     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01036.x     Document Type: Article

References (20)

1. Baekeland F, Lundwall L: Dropping out of treatment: A critical review. Psychol Bull 82:738-783, 1975
2. Planansky K, Johnston R: A survey of patients leaving a mental hospital against medical advice. Hosp Community Psychiatry 27:865-868, 1976
3. Crowe DB, Rosse RB, Sheridan MJ, Deutsch SI: Substance use diagnoses and discharge patterns among psychiatric inpatients. Hosp Community Psychiatry 42:403-405, 1991
4. Spilker B: Guide to Clinical Trials. New York, Raven Press, 1991
5. Spriet A, Simon P: Methodology of Clinical Drug Trials (translated by R. Edelstein, M. Weintraub). Basel, Karger Publishers, 1985
6. Meyer RE: Some issues in the evaluation of a pharmacotherapy of alcoholism, in Naranjo CA, Sellers EM (eds): Novel Pharmacological Interventions for Alcoholism. New York, Springer-Verlag, 1992, pp 40-55
7. Blaine JD, Ling W, Kosten TR, O'Brien CP, Chiarello RJ: Establishing the efficacy and safety of medications for the treatment of drug dependence and abuse: Methodologic issues, in Prien RF, Robinson DS (eds): Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. New York, Raven Press, 1994, pp 593-623
8. Gainey RR, Wells EA, Hawkins JD, Catalano RF: Predicting treatment retention among cocaine users. Int J Addict 28:487-505, 1993
9. Sparr LF, Moffitt MC, Ward MF: Missed psychiatric appointments: Who returns and who stays away. Am J Psychiatry 150:801-805, 1993
10. Waldrop MM: NIDA aims to fight drugs with drugs. Science 245: 1443-1444, 1989
11. Klein DF: Improvement of phase III psychotropic drug trials by intensive phase II work. Neuropsychopharmacology 4:251-258, 1991
12. Trivedi MH, Rush J: Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 11:33-43, 1994
13. Norusis MJ/SPSS, Inc.: SPSS for Windows: Advanced Statistics, release 5. Chicago, SPSS, Inc., 1992
14. Cohen J, Cohen P: Applied Regression/Correlation Analysis for the Behavioral Sciences, ed 2. Hillsdale, NJ, Erlbaum, 1983
15. Hesselbrock MN, Meyer RE, Keener JJ: Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 42:1050-1055, 1985
16. Ross HE, Glaser FB, Germanson T: The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 45:1023-1031, 1988
17. Mammo A, Weisbaum DF: Some factors that influence dropping out from outpatient alcoholism treatment facilities. J Stud Alcohol 54:92-101, 1993
18. Manu P, Burleson JA, Kranzler H: Patient predictors of irregular discharge from inpatient substance abuse treatment. Am J Addict 3:122-128, 1994
19. Kleinman PH, Kang SY, Lipton DS, Woody GE, Kemp J, Millman RB: Retention in cocaine abusers in outpatient psychotherapy. Am J Drug Alcohol Abuse 18:29-43, 1992
20. Rosenthal R: The "file drawer problem" and tolerance for null results. Psychol Bull 86:638-641, 1979